Alcon demonstrates potential resilience vs. market shocks, with favorable balance sheet risk and positive EPS forecasts for FY26. Read why ALC stock is a Buy.

According to the latest study published by Vyansa Intelligence, the Global Contact Lenses and Solutions Market ...

Vision Care delivered Q4 sales of $1.2 billion, up 7% year on year, as the segment benefited from innovation and pricing actions. Contact Lens revenue increased 4% to $683 million despite tough ...

Lensar today entered into a priority credit line agreement in a move that analysts say casts doubt over its planned acquisition by Alcon.

The Federal Trade Commission said the transaction had threatened to raise prices and stifle innovation for cataract laser eye ...